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Cigarette smoke is a complex mixture of more than 8000 smoke constituents. The quantiﬁcation of
selected mainstream smoke constituent yields is one of the methods to evaluating and comparing the
performance of different products. Numerous regulatory and scientiﬁc advisory bodies have used ciga-
rette smoke constituent yield data for reporting and product comparison purposes. For more than a
decade limitations of the indiscriminate application of traditional statistical methods such as the t-test
for differences in comparative smoke constituent yield assessments lacking a speciﬁc study design, have
been highlighted. In the present study, the variability of smoke constituent yields is demonstrated with
data obtained under the ISO smoking regime for the Kentucky reference cigarette 3R4F and one com-
mercial brand, analyzed on several occasions between 2007 and 2014. Speciﬁcally it is shown that
statistically signiﬁcant differences in the yields of selected smoke constituents do not readily translate to
differences between products, and that tolerances need to be deﬁned. To this end, two approaches have
been proposed in the literature e minimal detectable differences, and the statistical equivalence. It is
illustrated how both approaches provide more meaningful comparison outcomes than the statistical t-
test for differences. The present study provides considerations relevant for comparative tobacco product
assessments both in the scientiﬁc and regulatory contexts.
© 2015 Philip Morris Products S.A. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cigarette smoke is a complex mixture of more than 8000
chemical compounds (Rodgman and Perfetti, 2013). The quantiﬁ-
cation of cigarette smoke constituents yields beyond ‘tar’, nicotine
and carbon monoxide (CO) is one of the methods for characterizing
tobacco products emissions, and the disclosure of such data is a
regulatory requirement in several countries, for example Brazil,
Canada, Taiwan, and the U. S. (Brazil National Health Surveillance
Agency ANVISA, 2007; Health Canada, 2000; Taiwan Ministry of
Health and Welfare - Health Promotion Administration, 2012; U.S.
Food and Drug Administration, 2010). Since it is not feasible to
quantify all compounds in cigarette smoke, a selection of smoke
constituents for quantiﬁcation is generally made, based on risk
assessment (Haussmann, 2012; Hoffmann and Wynder, 1986;
Talhout et al., 2011). Several smoke constituents lists have beenelushkin).
ed by Elsevier Inc. This is an openproposed, including the Health Canada list (Health Canada, 2012)
and the U.S. Food and Drug Administration list (U.S. Food and Drug
Administration, 2012).
It has been stated that the yields of individual smoke constitu-
ents are not directly predictive of health effects in humans
(Rodgman and Perfetti, 2013; U.S. Food and Drug Administration,
2011). The yields of selected smoke constituents are generally
considered to characterize product performance. In addition to
regulatory reporting, quantitative comparisons of yields from
different products are often sought, and regulatory proposals based
on quantitative comparisons of smoke constituent yields have been
made (Burns et al., 2008; U.S. Food and Drug Administration, 2011;
World Health Organization, 2008). It is therefore important that
appropriate statistical tools are employed for reporting and
comparing smoke constituent yields.
The two most basic questions which can be addressed in a
product comparison are whether a difference exists between a pair
of products, or whether the two products are equivalent. The two
most frequently employed statistical tools to address these ques-
tions are the statistical t-test for differences, and the statisticalaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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With respect to smoke constituent yield comparisons, whilst the
statistical t-test for differences certainly has its value in controlled
study designs involving the quantiﬁcation of only a few smoke
constituents, for examplewhen evaluating the potential impact of a
product change on a single smoke constituent, yields from the same
product measured for multiple smoke constituents on different
occasions may appear statistically different (Baker et al., 2004).
Moreover, it may not always be practical or feasible to require that
the same smoke constituents are measured on exactly the same
occasions for all products even within a controlled study design,
especially in cases where many smoke constituents are quantiﬁed
for many products. More generally, two major limitations of the
statistical t-test for differences in its application to smoke constit-
uents yield evaluations have been discussed.
The ﬁrst is a statistical consideration. The t-test is performed
with a certain probability to falsely conclude a difference when
there is none, and to falsely fail to conclude a difference when there
is one. These probabilities may be chosen by means of a risk-based
approach a priori, and often the choice is made to set the probability
of falsely concluding a difference to 5%, or one out of 20. It is
important to note that the t-test itself is applied to each smoke
constituent individually, but an apparent difference in the yield of
any one smoke constituent often leads to the conclusion of a dif-
ference between products. Considering that multiple smoke con-
stituents are tested, the probability to conclude a difference
between products when there is none is very much higher: 60% if
18 smoke constituent yields are compared between products (U.S.
Food and Drug Administration, 2012), 90% if 44 smoke constitu-
ent yields are compared (Health Canada, 2012), and greater than
99% if 96 smoke constituent yields are compared (U.S. Food and
Drug Administration, 2012). This can be overcome by either
accepting that, on average, when testing N smoke constituents
between a pair of products at a Type-I error rate of 5%, the number
of statistically signiﬁcant differences will be 0.05*N, or alternatively
by applying appropriate multiple comparisons corrections (Miller,
1981) that generally need to be considered regardless of the type
of statistical test applied (Verron et al., 2014).
The other, and more important limitation of the t-test relates to
the so-called long-term variability phenomenon due to analytical,
agricultural, and manufacturing sources (International
Organization for Standardization, 2013a; Purkis et al., 2012). It
should be noted the term long-term is used to differentiate from
the normal measurement variability, and is linked to different
smoking runs, whether conducted close or far apart in time.
Essentially, in this context, short-term measurement variability
is the variability which can be observed between different repli-
cates within one measurement series. The main contributions to
short-term variability derive from the fact that the cigarette sample
is destroyed during the smoke generation process, therefore sub-
sequent replicates need to be obtained from different cigarette
samples; variability of smoke generation from a given smoking
machine; and variability of sample handling and analytical
methods, especially during the determination of extremely low
nanogram level concentrations (Horwitz and Albert, 2006) of many
smoke constituents (Counts et al., 2004, 2006; Dolka et al., 2013).
Analytical variability is in part a consequence of the absence of
validated standard methods for measuring the majority of smoke
constituents (e.g., International Organization for Standardization
(ISO)-standard methods). Indeed, ISO-standard methods have been
established only for ‘tar’ (International Organization for
Standardization, 2000b), nicotine (International Organization for
Standardization, 2013b), water (International Organization for
Standardization, 1999; International Organization for
Standardization, 2013c), CO (International Organization forStandardization, 2007), benzo[a]pyrene (International
Organization for Standardization, 2008), and menthol
(International Organization for Standardization, 2012). ISO stan-
dard methods for the quantiﬁcation of smoke constituents should
not be confused with ISO standards for sampling (International
Organization for Standardization, 2013a) and machine-smoking
conditions (International Organization for Standardization, 2000a).
In contrast, many effects may contribute to the long-term vari-
ability: different cigarette samples may potentially come from
different manufacturing runs (manufacturing variability compo-
nent) and/or contain tobaccos from different crop years and origins
(agricultural variability component); variability of smoke genera-
tion may result from using different smoking machines, and vari-
ability in sample handling and analytical methods may arise from
different laboratory technicians (analytical variability component).
The agricultural and manufacturing variability components
have their roots in the fact that tobacco is an agricultural product,
and may exhibit different characteristics between different crop
years or origins. Even tobacco from the same region and crop year
but different farms may have different characteristics. In many
commercial products, such agricultural differences would be
partially accounted for by blending. The manufacturing process
however, for example the use of different tobacco lots to produce
the same cigarette brands on different production runs, adds
another level of product variability.
Variations not attributable to normal measurement variance can
exist in values reported both between laboratories (Intorp and
Purkis, 2010; Intorp et al., 2012a, 2012b, 2011), and within a sin-
gle laboratory on different occasions (Baker et al., 2004; Eldridge
et al., 2015; Purkis et al., 2012). Inter-laboratory comparisons
have been discussed at great length previously (Intorp and Purkis,
2010; Intorp et al., 2012a, 2012b, 2011; Purkis et al., 2012; Teillet
et al., 2013), and are not within the scope of the present study
which focuses on intra-laboratory yield variability. The exact ori-
gins and partitioning of analytical, manufacturing, and agricultural
variance within the total variance have not been fully clariﬁed
(Eldridge et al., 2015; Hanna et al., 2014; Minagawa, 2012), and the
subject is currently being studied by a new Task Force on
Manufacturing Variability within the Cooperation Centre for Sci-
entiﬁc Research Relative to Tobacco (CORESTA).
These aspects of variability introduce systematic bias between
measurements, and have been widely discussed in the literature
(International Organization for Standardization, 2013a; Oldham
et al., 2014; Purkis et al., 2011, 2010a, 2012, 2010b; Teillet et al.,
2013). To minimize the possible impact of these sources of vari-
ance on the results, one could either measure the same smoke
constituent on the same occasion, same smoking machine, by the
same operator, on all products in a study, or measure smoke con-
stituents on many batches of each product over a very long period
of time. In the ﬁrst scenario, the impact of analytical variability
arising between different smoking runs would be minimized; in
the second scenario, long-term variability would be accounted for
in the variance of the measurement directly. However, it is not al-
ways practical or feasible to realize any of these scenarios in
product comparison studies, especially when they involve the
quantiﬁcation of many smoke constituents across many products,
or when the assessments are post-hoc assessments of e.g. smoke
constituent yields reported to regulatory authorities on a routine
basis.
The goal of the present study is to illustrate with smoke con-
stituent yield data obtained for the same products over a total
period of eight years, the practical limitations of the statistical t-test
for differences, and show that they cannot be fully accounted for
through multiple testing corrections, but consideration of the long-
term variability is crucial to obtain meaningful comparison results.
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detectable differences approach (Oldham et al., 2012; Roemer and
Carchman, 2011) overcomes the main difﬁculties associated with
the interpretation of results of the t-test for differences. In addition,
it is demonstrated how empirical estimates of the long-term vari-
ability can be employed to calculate equivalence ranges for product
equivalence assessments employing the statistical equivalence test
(Berger and Hsu, 1996; Limentani et al., 2005).
2. Methods
Data from several independent studies conducted in three ISO
17025 (International Organization for Standardization, 2005)
accredited laboratories were used for the present work. These
laboratories are further referred to as Laboratory 1, Laboratory 2,
and Laboratory 3. Data obtained under the ISO smoking regime
were considered based on availability, although the discussion of
the present manuscript is equally applicable to other smoking re-
gimes (International Organization for Standardization, 2000a).
The ﬁrst part of the present study examined data on the yields of
the Health Canada list of 44 smoke constituents obtained for the
reference cigarette 3R4F obtained in the course of four studies
performed at a single laboratory using its own analytical methods:
Study 1 was conducted in 2012, Study 2 and Study 3 were con-
ducted in 2013, and Study 4 was conducted in 2014. In each study,
the yields of each of the smoke constituents from the Health Can-
ada list was quantiﬁed in three replicates, with the exception of
‘tar’, nicotine and CO which were quantiﬁed in eight replicates
each.
The second part of the study examined data on the yields of a
selection of several smoke constituents obtained in proﬁciency
trials organized by Philip Morris International between the years
2007 and 2014, in each of the three laboratories, for the reference
cigarette 3R4F and one commercial brand (Marlboro Gold). The
smoke constituents were nicotine, CO, N’-nitrosonornicotine
(NNN), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK),
formaldehyde, and acrolein for the reference cigarette 3R4F. The
smoke constituents were nicotine, NNN, and formaldehyde for the
commercial cigarette brand. The laboratories used their own
methods, with the exception of the determination of nicotine and
CO, which were analyzed according to the corresponding ISO
standards. In 2007, the study design allowed for ﬁve smoking
replicates on each of three measurement days. In 2009, 2010 and
2012 the study design allowed for four smoking replicates on each
of three days, while in 2014 four smoking replicates were run on
two measurement days.
Following an evaluation of the study results by means of the
statistical t-test for differences, the application of the minimal
detectable differences approach for the assessment of product yield
differences, and the application of the statistical equivalence
approach for the assessment of product yield equivalence, is
illustrated.
The minimal detectable differences (MDD) approach (Oldham
et al., 2012; Roemer and Carchman, 2011) is based on the statisti-
cal t-test for differences, and as such can be applied when the
objective of an analysis is to determine differences in yields be-
tween products. The approach is based on the notion of using long-
term variability data generated throughout prior studies, to over-
come some of the limitations associated with the use of the t-test.
Effectively, for each apparent statistically signiﬁcant difference, it is
evaluated whether the difference would have been statistically
signiﬁcant if the relative variance of themeasurement was replaced
by the long-term relative variance of the 3R4F reference cigarette,
thereby accounting for the effects of long-term analytical vari-
ability. Operationally, this approach amounts to performing thestatistical t-test for differences at a chosen Type-I error rate a, and
evaluating the magnitude of statistically signiﬁcant differences
against the MDD values calculated based on long-term 3R4F
reference cigarette data following the approach described in detail
in (Oldham et al., 2012). Differences below the MDD, even when
statistically signiﬁcant, cannot be considered meaningful as they
are effectively below the resolution of the method.
The yields of the 3R4F reference cigarette are considered for the
empirical evaluation of the analytical long-term variability since
this reference cigarette was produced at a single point in time from
a single set of tobacco lots. As a consequence, the agricultural and
manufacturing variability components can be considered as
minimal.
The statistical equivalence approach is based on the statistical
equivalence test (Berger and Hsu, 1996; Limentani et al., 2005),
which has the requirement that some equivalence range is speci-
ﬁed prior to conducting the analysis. In some industries, regulatory
requirements specifying appropriate equivalence ranges have been
developed (European Medicines Agency Committee for Medicinal
Products for Human Use, 2010; U.S. Food and Drug
Administration, 2001), and can be related to variability of the
product under assessment (Dangi et al., 2010; European Medicines
Agency Committee for Medicinal Products for Human Use, 2010). In
the absence of speciﬁc equivalence range guidelines for tobacco
products, in the present study the application of the approach is
illustrated using equivalence ranges calculated based on long-term
variance of the 3R4F reference cigarette, similar to (Dolka et al.,
2013). The choice of the equivalence range follows the empirical
observation that for any of the assessed smoke constituents, the
mean of the 3R4F reference cigarette obtained on any single mea-
surement occasion does not generally appear to deviate from the
long-termmean bymore than 3 standard deviations; consequently,
the difference between two means can reasonably be expected to
be conﬁned to the interval 3√2 standard deviations, or 3√2 rela-
tive standard deviations of long-term 3R4F measurements for
normalized yield differences.
3. Results
3.1. Statistical differences between reference cigarette 3R4F yields
obtained in the same laboratory on different measurement
occasions
Data obtained for the smoke constituent yields of the reference
cigarette 3R4F at Laboratory 1 on four measurement occasions
(Study 1 conducted in 2012, Study 2 and Study 3 both conducted in
2013, and Study 4 conducted in 2014) was analyzed.Without loss of
generality, smoke constituent yields obtained in Studies 2, 3, and 4
were compared to smoke constituent yields obtained in Study 1 by
means of the statistical t-test for differences at a Type-I error rate of
5%. Results for yield differences between study pairs were
expressed as a percentage of the historical data for the reference
cigarette 3R4F obtained in Laboratory 1 over a period of no less than
one year (Fig. 1). For each comparison, numerous statistically sig-
niﬁcant differences in the yields were observed. The comparison
Study 2 e Study 1 identiﬁed 9 statistically signiﬁcantly different
smoke constituent yields, the comparison Study 3 e Study 1
identiﬁed 11 statistically signiﬁcantly different smoke constituent
yields, and the comparison Study 4 e Study 1 identiﬁed 11 statis-
tically signiﬁcantly different smoke constituent yields. Only cate-
chol, N’-nitrosoanatabine (NAT), and nicotine were statistically
signiﬁcantly different in all three comparisons. Largest differences
were observed in the yields of pyridine (Study 2 e Study 1) and
catechol (Study 4 e Study 1) (up to 50%-level differences), and 1-
aminonaphthalene (Study 3 e Study 1), 1,3-butadiene (Study 3 e
Fig. 1. Results of three studies on the reference cigarette 3R4F (Study 2 and Study 3 conducted in 2013, and Study 4 conducted in 2014) compared to results obtained in 2012 (Study
1). Circles show yield differences normalized to the long-term reference cigarette 3R4F historical value for the laboratory, error bars show corresponding 95% conﬁdence intervals.
Numerous statistically signiﬁcant differences at a 95% conﬁdence level are observed (solid circles). HCN e hydrogen cyanide; NO e nitric oxide; NOx e nitrogen oxides; CO e carbon
monoxide; NNN e N’-nitrosonornicotine; NAT - N'-nitrosoanatabine; NAB e N’-nitrosoanabasine; NNK - 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
M. Belushkin et al. / Regulatory Toxicology and Pharmacology 73 (2015) 105e113108Study 1), benzo[a]pyrene (Study 2 e Study 1), cadmium (Study 3 e
Study 1), mþp-cresols (Study 4 e Study 1), and nitrogen oxides
(Study 3 e Study 1) (20%e30% level differences).
A further comparison between Study 2 and Study 3 revealed 9
statistically signiﬁcant differences, Study 2 and Study 4 identiﬁed 8
statistically signiﬁcant differences, and Study 3 and Study 4 iden-
tiﬁed 14 statistically signiﬁcant differences (data not shown).
3.2. Variability of average yields of selected smoke constituents
from the reference cigarette 3R4F in different laboratories
Data obtained for the yields of a selection of six smoke con-
stituents from the reference cigarette 3R4F at three laboratories as
part of several proﬁciency trials conducted between 2007 and 2014
are shown in Fig. 2. The results show that the variability of yields
and its magnitude are not speciﬁc to one single laboratory, but are
consistent between the three laboratories considered.
For a given smoke constituent, the differences between the
average yields for a given laboratory are generally of the same
magnitude between all laboratories, but are different for different
smoke constituents. Nicotine and CO vary on a scale of ±10%.
Acrolein, NNN, and NNK varied on a scale of ±15%. Formaldehyde
varied on a scale of ±40%. These values are in broad agreement with
long-term variability observed for the reference cigarette 3R4F in
other studies (Eldridge et al., 2015).3.3. Variability of average yields of selected smoke constituents
from a commercial cigarette brand in different laboratories
Data obtained for the yields of a selection of three smoke con-
stituents from the Marlboro Gold commercial cigarette brand at
three laboratories as part of several proﬁciency trials conducted
between 2007 and 2014 are shown in Fig. 3.
For a given smoke constituent, the differences between the
average yields for a given laboratory are generally of the same
magnitude between all laboratories, but are different for different
smoke constituents. Nicotine, NNN and formaldehyde varied on a
scale of ±10%, ±35%, and ±50%, respectively.
3.4. Application of alternative data evaluation approaches
The common ingredient for the application of both the minimal
detectable differences and of the statistical equivalence approaches
is the availability of long-term variability evaluated for the refer-
ence cigarette 3R4F. In the present study, between 100 and 1000
replicates per smoke constituent obtained over a period of more
than a year were available for the long-term variability assessment.
The application of both approaches to data for the reference
cigarette 3R4F obtained in the same laboratory within four separate
studies, is shown in Fig. 4. The yields of the majority (but not all) of
smoke constituents are within the chosen tolerance limits of 3√2
Fig. 2. Variation in yields of selected analytes in different studies conducted on the reference cigarette 3R4F in three different laboratories. Differences of each study to the average
of all shown studies per laboratory are shown. The magnitude of variation is comparable between the different laboratories, but differs substantially for different analytes. Error bars
show the 95% conﬁdence intervals. NNN e N’-nitrosonornicotine; NNK e 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
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normalized yield differences.
4. Discussion
Results of four studies performed in Laboratory 1 analyzed by
means of the statistical t-test for differences (Section 3.1) could
have suggested that the four studies were performed with four
different products. In fact, all analyzed data were obtained from the
reference cigarette 3R4F, which was produced from a single set of
tobacco lots at essentially the same point in time. If the differences
were solely due to failure to apply multiple-testing corrections, the
number of statistically signiﬁcant differences would average
0.05*N, or about 2 per pairwise comparison as just under 40 smoke
constituents are shown in Fig. 1. However, the average number of
statistically signiﬁcant differences per pairwise comparison is
about 10. Consequently, the numerous observed statistically sig-
niﬁcant differences in yield determination are due essentially to
analytical long-term variability.
This phenomenon is not speciﬁc to one laboratory. Indeed, the
comparison of variation in smoke constituent yields of thereference cigarette 3R4F between different laboratories shows
differences of similar magnitudes (Section 3.2).
For commercial cigarette brands, in addition to the analytical
variability component captured in the long-term variance of the
3R4F reference cigarette, these differences can reasonably be ex-
pected to exceed those observed for the reference cigarette 3R4F
due to a combination of both agricultural and manufacturing
variability. This is indeed the case as shown for the single com-
mercial cigarette brand (Section 3.3).
Consequently, to avoid the false conclusion of a difference be-
tween products, approaches other than the smoke constituent level
statistical t-test for differences are required. Such approaches
should recognize that there exists bias in the determination of
smoke constituents' yields which, in the absence of standardized
and validated methods can be accounted for by deﬁning some level
of tolerance on natural, acceptable differences. Indeed, an ISO
standard for pack printed values of ‘tar’, nicotine, and CO recognizes
the long-term variability of yields through the establishment of
minimum acceptable conﬁdence intervals (International
Organization for Standardization, 2013a).
The necessity of taking into account the long-term variability of
Fig. 3. Variation in yields of selected analytes in different studies conducted on the Marlboro Gold commercial cigarette brand, in three different laboratories except formaldehyde,
for which data from two laboratories is available. Differences of each study to the average of all shown studies per laboratory are shown. The magnitude of variation is comparable
between the different laboratories, but differs substantially for different analytes, and with the exception of nicotine exceeds the variation observed for the reference cigarette 3R4F
(Fig. 2). Error bars show the 95% conﬁdence intervals. NNN e N’-nitrosonornicotine.
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notable approaches have been proposed to this end e the MDD
approach (Oldham et al., 2012; Roemer and Carchman, 2011), and
the statistical equivalence approach (Berger and Hsu, 1996;
Limentani et al., 2005). They provide answers to two different
statistical questions - in particular, failure to conclude a difference
in a statistical test for differences generally does not allow to
conclude equivalence, and conversely failure to demonstrate
equivalence generally does not lead to the conclusion of a differ-
ence. However, both approaches are based on the same notion,
namely that to provide a meaningful comparative assessment of
smoke constituent yields it is imperative to empirically estimate
the long-term variability associated with the yields of each smoke
constituent. This estimation is based on the yields of the reference
cigarette 3R4F measured in the same laboratory over a large
number of smoking runs.
The application of the MDD and the statistical equivalence ap-
proaches to smoke constituent yields evaluations is illustrated in
Fig. 4. The tolerance range was selected based on the individual
measurement occasions for the 3R4F reference cigarette in the
same laboratory, such that these measurements are found within
the chosen tolerance.
This approach is generally in line with an ISO standard
describing the tolerances around the printed values of ‘tar’, nico-
tine, and CO, which take into account short- and long-term
analytical and manufacturing variability (International
Organization for Standardization, 2013a). In fact, the tolerance
ranges in the present study for ‘tar’, nicotine, and CO are at the level
of 20%, in line with the one point in time sampling conﬁdence in-
tervals provided in the ISO standard (International Organization for
Standardization, 2013a). It is therefore reasonable to conclude that
until a comparable level of validation and standardization work is
carried out for other smoke constituents, empirical approaches
such as those described in the presentworkwill remain useful tools
for the assessment of meaningful yield differences.
This assessment reveals that, despite the observation that the
yields of a small number of smoke constituents are not entirely
within the tolerances, their number is well in line with the ex-
pected 0.05*N, therefore it can be concluded that both theapplication of the MDD and of the equivalence approach correctly
show that the statistically signiﬁcant differences seen with the
application of the t-test are not meaningful. In other words, the
observed differences are attributable to the long-term analytical
variability, and are not due to product differences.
It should be further remarked that the MDD approach is based
on the statistical t-test for differences. As such, the MDD approach
should be applied when the objective is to identify differences in
the yields of individual smoke constituents, and it does not permit
to draw statistical conclusions regarding equivalence of yields. The
approach based on the equivalence test, on the other hand, is
applicable when the objective is to establish equivalence of yields
of individual smoke constituents, and the choice of a particular
tolerance range should be in line with the design of the study and
variability of the product.
The choice of a speciﬁc deﬁnition of tolerance limits also re-
mains an open question and a subject for further investigations. For
example, when applying the equivalence approach, the equivalence
range must be chosen a priori. The choice in the present work is in
line with previous studies where it was shown to differentiate well
between products where ﬁltration was affected (Dolka et al., 2013),
and provides generally reasonable results by not differentiating the
same products in the majority of smoke constituents except a
number well in line with the expected 0.05*N (Fig. 4).
The situation is further complicated when attempting to
compare smoke constituent yields obtained in different labora-
tories, whereby systematic inter-laboratory differences also need to
be accounted for (Purkis et al., 2012).
5. Conclusions
There exists a substantial variability of smoke constituent yields
from the same cigarette product smoked on different occasions,
which is referred to as long-term variability to differentiate it from
normal short-term measurement variance. This variability has
complex roots stemming from analytical methods, as well as
manufacturing and agricultural sources.
This carries considerable implications for quantitative smoke
constituent yields comparisons. In particular, it precludes the use of
Fig. 4. Results of three studies on the reference cigarette 3R4F (Study 2 and Study 3 conducted in 2013, and Study 4 conducted in 2014) compared to results obtained in 2012 (Study
1). Circles show yield differences normalized to the long-term reference cigarette 3R4F historical value for the laboratory, error bars show corresponding 90% conﬁdence intervals.
Green boxes show an empirically calculated chosen equivalence range (in this example the choice was made ± 3 √2 RSD, where RSD is the historical relative standard deviation).
Equivalence of yields can be concluded when the 90% conﬁdence interval is fully contained within the equivalence ranges. Blue triangles denote the limits calculated using the MDD
approach, whereby the sample size is three. HCN e hydrogen cyanide; NO e nitric oxide; NOx e nitrogen oxides; CO e carbon monoxide; NNN e N’-nitrosonornicotine; NAT - N'-
nitrosoanatabine; NAB e N’-nitrosoanabasine; NNK - 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. (For interpretation of the references to color in this ﬁgure legend, the reader
is referred to the web version of this article.)
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erroneous conclusions of differences between yields are inevitable
even when the yields refer to the same cigarette product manu-
factured on the same occasion and smoked in the same laboratory.
Several methodologies have been proposed to account for long-
term variability, by empirically calculating tolerance limits below
which differences in yields cannot be considered meaningful. The
choice of themethodology and tolerances should be in linewith the
objectives of a given study, such as reporting, demonstrating a
difference, a doseeresponse relationship, or equivalence in the
yields of a particular smoke constituent or class of smoke constit-
uents. For example, if a novel technology is applied which is ex-
pected to have an impact on a certain class of smoke constituents, a
study may be designed to test that speciﬁc hypothesis. In this case,
many components of variability may be substantially reduced by
means of the study design, e.g., use of the same tobacco and ﬁlter
lots for cigarette production, use of the same smoking machine and
laboratory personnel for sample handling and analyses, etc. How-
ever, more generally, the conditions for minimizing variability over
multiple classes of smoke constituents, as well as over multipleproducts especially if smoked at different times, usually cannot be
guaranteed.
In any case, the relationship between yields of individual smoke
constituents and differences or equivalence of products is not a
simple one. In particular, it may not be reasonable to deﬁne dif-
ferences between products if yields of a small number of smoke
constituents appear different, nor would it be reasonable to de-
mand equivalence of yields of all smoke constituents to conclude
equivalence between products. At a minimum, it should be
accepted and understood that because the tests on individual
smoke constituents are performed with some chosen probability of
false positive and false negative outcomes, among 18, 40, or 98
smoke constituents, a proportionate number will be expected to
fail the statistical test.
Consequently, in addition to the use of experimental designs
and statistical methods ﬁt for the purpose in combination with
tolerance limits to account for long-term variability, further
investigation of the phenomena associated with long-term vari-
ability is critical to enable the implementation of statistical meth-
odologies capable of providing deﬁnitive answers with respect to
M. Belushkin et al. / Regulatory Toxicology and Pharmacology 73 (2015) 105e113112product evaluations based on a quantitative comparison of a large
number of smoke constituent yields and in the absence of a tar-
geted experimental design, especially as smoke constituent yields
are generally not independent but exhibit complex inter-
relationships (Piade et al., 2013). Consequently, statistical signiﬁ-
cance of results obtained in individual smoke constituent com-
parisons should when interpreted at the product level take into
account consideration of statistical error rates associated with the
individual comparisons, e.g. by accepting that across N constitu-
ents, on average 0.05*N individual comparisons may provide false
ﬁndings.
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